These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35454322)

  • 1. MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review.
    Bougea A
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454322
    [No Abstract]   [Full Text] [Related]  

  • 2. microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes.
    Bougea A; Stefanis L
    Adv Clin Chem; 2023; 115():83-133. PubMed ID: 37673523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
    Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
    Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.
    Nonaka W; Takata T; Iwama H; Komatsubara S; Kobara H; Kamada M; Deguchi K; Touge T; Miyamoto O; Nakamura T; Itano T; Masaki T
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature.
    Bougea A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.
    Taha HB; Bogoniewski A
    J Neurol; 2024 Apr; 271(4):1680-1706. PubMed ID: 38103086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F; Barron DS; Tantiwongkosi B; Fox P
    Brain Behav; 2015 Jun; 5(6):e00329. PubMed ID: 26085961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical findings: Atypical parkinsonian syndromes or Atypical parkinsonian syndromes look-alikes.
    Calikusu FZ; Akkus S; Kochan Kizilkilic E; Poyraz BC; Altunç AT; Kiziltan G; Gunduz A
    Clin Neurol Neurosurg; 2023 Oct; 233():107975. PubMed ID: 37734268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
    Rana AQ; Qureshi AR; Siddiqui O; Sarfraz Z; Rana R; Shtilbans A
    J Neurol; 2019 Sep; 266(9):2093-2102. PubMed ID: 30238268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
    Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
    Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
    Stamelou M; Quinn NP; Bhatia KP
    Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP).
    Tatura R; Buchholz M; Dickson DW; van Swieten J; McLean C; Höglinger G; Müller U
    Neurogenetics; 2016 Jul; 17(3):165-71. PubMed ID: 27052995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson's disease and atypical Parkinsonian syndromes.
    Schröter N; van Eimeren T; Classen J; Levin J; Redecker C; Wolz M; Tönges L
    J Neural Transm (Vienna); 2023 Jun; 130(6):839-846. PubMed ID: 37046147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical Parkinson syndromes--recent advances in diagnosis and therapy].
    Duerr S; Wenning GK; Seppi K; Poewe W
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):492-500. PubMed ID: 22457226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.